XTalks

SEPTEMBER 15, 2020

A vaccine developed by Swedish company Diamyd Medical has demonstrated significant treatment efficacy in a predefined genetic subgroup of individuals with type 1 diabetes in a Phase IIb clinical trial. In the trial, the vaccine was injected directly into the lymph nodes of type 1 diabetic individuals.

Vaccine 103

Vaccine Vaccination Insulin Trials 103

XTalks

SEPTEMBER 8, 2020

The company has signed on to help manufacture AstraZeneca’s COVID-19 vaccine candidate, AZD1222, intended to protect against the SARS-CoV-2 novel coronavirus. AMRI is proud to partner with AstraZeneca in pursuit of a vaccine that could protect people against the coronavirus pandemic,” said John Ratliff, CEO of AMRI, in a statement.

Manufacturing 83

Manufacturing Vaccine Vaccination Allergies 83

XTalks

NOVEMBER 6, 2020

Canadian clinical-stage biotech company Symvivo Corporation has developed an oral COVID-19 vaccine that entered clinical trials this week. The first healthy volunteer was dosed with the vaccine in Australia as part of the bacTRL-Spike COVID-19 Phase I clinical trial. Related: Red Meat Allergy Test Gets FDA Clearance. “We

Clinical Trials 75

Clinical Trials Clinical Trials Vaccine Vaccination 75

XTalks

FEBRUARY 22, 2021

(NASDAQ: PFE ) and BioNTech SE (Nasdaq: BNTX ) revealed they have submitted new data to the US Food and Drug Administration (FDA) that demonstrates the stability of their COVID-19 vaccine when stored at common freezer temperatures of -25°C to -15°C for pharmaceutical products. The vaccine is injected at room temperature by medical staff.

Vaccine 69

Vaccine Vaccination Pharmacy Manufacturing 69

XTalks

FEBRUARY 11, 2021

Amidst growing global shortages of COVID-19 vaccine supplies, inaugural (by way of authorizations/approvals) COVID-19 vaccine maker Pfizer is addressing the issue by working to cut the manufacturing time of its vaccine by almost half. Related: Pharma Rivals Step Up to Assist with COVID-19 Vaccine Production.

Manufacturing 52

Manufacturing Vaccine Vaccination DNA 52

XTalks

JANUARY 27, 2021

COVID-19 vaccine maker Moderna announced this week that results from a study show that the shot is effective against some of the new circulating variants of SARS-CoV-2. In a news release from Moderna, the company reported that the administration of its COVID-19 vaccine induced antibody titers against both variants.

Vaccine 52

Vaccine Vaccination In-Vitro Protein 52

The Pharma Data

APRIL 22, 2023

The current COVID-19 vaccines are designed to trigger an antibody response to the SARS-CoV-2 spike protein, which is vulnerable to mutations that could make the vaccine less effective over time. of the mice that were vaccinated with the T-cell-based vaccine survived, while only one of the control-group mice survived.

Vaccine 40

Vaccine Vaccination Protein Antibody 40

The Pharma Data

JANUARY 6, 2021

Under the terms of the agreement, Bayer will support the further development, supply and key territory operations of CureVac’s COVID-19 vaccine candidate CVnCoV. “The need for vaccines against COVID-19 is enormous. “We are highly committed to making our capabilities and networks available to help end this pandemic.”

Vaccination 52

Vaccination Vaccine Development Production 52

The Pharma Data

DECEMBER 23, 2020

” Dr. Stanley Plotkin , Professor Emeritus at The Wistar Institute, said, “INOVIO’s DNA vaccine appeared to be quite safe with few significant reactions but yet induced both antibody and T cell responses to SARS-CoV-2.” . PLYMOUTH MEETING, Pa. , The participants were enrolled into 1.0

DNA 40

DNA Vaccination Vaccine Immune Response 40

XTalks

MAY 7, 2021

As Novavax awaits emergency use authorization (EUA) from the US Food and Drug Administration (FDA) for its protein-based COVID-19 vaccine NVX-CoV2373, the company shared new data this week on the vaccine’s efficacy against the South African B.1.351 That analysis also showed that the Novavax COVID-19 vaccine was 96.4

Protein 97

Protein Vaccine Vaccination Trials 97

XTalks

FEBRUARY 12, 2021

On the heels of news that AstraZeneca/Oxford’s COVID-19 vaccine has markedly reduced effectiveness against the B.1.351 1.351 variant of SARS-CoV-2 that first appeared in South Africa, the vaccine makers are going full steam ahead to make a variant booster shot against the strain. 1.351 between the vaccine and placebo groups.

Vaccine 105

Vaccine Vaccination Trials Antibody 105

XTalks

DECEMBER 7, 2021

VBI Vaccines got its first vaccine approval from the US Food and Drug Administration (FDA) for its hepatitis B shot PreHevbrio. And in another first, VBI’s shot is the only approved three-antigen HBV vaccine for adults in the US. PreHevbrio contains the S, pre-S2 and pre-S1 HBV surface antigens.

FDA Approval 103

FDA Approval Vaccine Vaccination Marketing 103

XTalks

DECEMBER 20, 2021

The World Health Organization (WHO) has backed Novavax’s COVID-19 vaccine, Covovax (NVX-CoV2373), by granting it an emergency use listing (EUL). The company is awaiting on authorization of its vaccine from regulatory health bodies around the world, including the US Food and Drug Administration (FDA) and Health Canada.

Vaccine 96

Vaccine Vaccination Protein Manufacturing 96

XTalks

FEBRUARY 3, 2021

Vaccine candidates from Novavax and Johnson & Johnson are looking to join the growing list of authorized COVID-19 vaccines as the companies recently posted positive efficacy data from large-scale Phase III trials evaluating their respective vaccines. Related: Moderna’s COVID-19 Vaccine Effective Against New Variants.

Vaccine 103

Vaccine Vaccination Trials Protein 103

XTalks

OCTOBER 26, 2023

The best way to prevent the flu is by getting vaccinated every year. The CDC and the World Health Organization (WHO) recommend annual flu vaccination for most people, especially those at high risk of serious complications, like pregnant women, elderly individuals, children and people with certain chronic health conditions.

Vaccine 105

Vaccine Vaccination RNA Manufacturing 105

XTalks

JANUARY 5, 2021

This year will see the rolling out of much-awaited pandemic-ending COVID-19 vaccines. The pandemic is expected to continue well into 2021 amidst the delivery and distribution of COVID-19 vaccines worldwide. Lockdowns and closures will continue to have staged implementations as the vaccines are phased in.

Life Science 98

Life Science Clinical Trials Clinical Trials Trials 98

XTalks

APRIL 26, 2021

After years of disappointing malaria vaccine trials, a malaria shot developed by researchers at the Jenner Institute at the University of Oxford has demonstrated an unprecedentedly high efficacy of 77 percent, and may be the magic bullet the world has been waiting for against the deadly disease.

Vaccine 105

Vaccine Vaccination Immune Response Trials 105

Delveinsight

JULY 29, 2020

The Government of India in order to contain the spread of novel coronavirus rolled out several guidelines and precautionary measures. Today the whole world is in a search for an effective vaccine candidate against SARS-CoV-2. The vaccine appears to be the only solution to prevent coronavirus.

Vaccine 62

Vaccine Vaccination Clinical Trials Clinical Trials 62

XTalks

MARCH 1, 2021

Though they both contain the same active ingredient, Cequa is an aqueous solution that contains a higher concentration of cyclosporin compared to Restasis. Since mask-associated dry eye is still under investigation and being described, there’s no consensus on its potential long-term effects.

Sales 119

Sales Drugs Life Science Containment 119

Pharmaceutical Technology

AUGUST 31, 2022

The COVID-19 pandemic and the resulting demand that it put on the pharmaceutical industry to supply vaccines, highlighted how the supply chain has several potential points of failure, making it much harder to control and predict.

Packaging 130

Packaging Packaging Production Containment 130

XTalks

AUGUST 3, 2021

Johnson and Johnson has faced thousands of lawsuits over its iconic baby powder, which people claim the company knew for decades contained asbestos. Talc and asbestos are often found together in nature, which is why mined talc can contain the carcinogen. Related: AstraZeneca Prevails in EU COVID-19 Vaccine Lawsuit. “We

Containment 98

Containment Production Contamination Marketing 98

STAT News

JULY 28, 2022

Can monkeypox be contained? Are snortable Covid-19 vaccines on the way? STAT’s Helen Branswell joins us to explain the latest in the monkeypox outbreak and how health authorities are struggling to contain it. And when is a GIF worth $200,000? Read the rest…

Life Science 98

Life Science Containment Vaccination Vaccine 98

XTalks

MAY 4, 2023

When a person with celiac disease eats something that contains gluten, their immune system attacks their small intestine, damaging the lining and interfering with the absorption of nutrients from food. Celiac disease is an autoimmune disorder that is triggered by the consumption of gluten, a protein found in barley, wheat and rye.

Clinical Trials 98

Clinical Trials Clinical Trials Trials Immune Response 98

Pharmaceutical Technology

SEPTEMBER 6, 2022

The list includes, but is not limited to, the providers of shipping and logistics for medical devices, diagnostics and life science products, cold chain logistics, storage and terminal services, value-added and financial services, trucking options for manufacturers, and digitalised pharmaceutical supply chain for improved visibility.

Containment 147

Containment Pharmacy Life Science Production 147

XTalks

AUGUST 18, 2020

Moreover, samples for the SalivaDirect test can be collected in any sterile container, and hence does not require any specific type of swab or collection vessel, making collection quick and easy. The diagnostic test has some unique features, including a novel method of processing saliva samples to test for COVID-19 infection.

FDA Approval 90

FDA Approval Reagent RNA Genome 90

XTalks

SEPTEMBER 27, 2021

The new Bad Ad quiz contains ten questions about how the program works, the measures that OPDP takes and how to report dubious ads. Related: FDA Authorizes COVID-19 Vaccine Boosters for Immunocompromised Individuals. “We Moreover, the pharmaceutical industry spent more than $24 billion on drug promotion in 2017, of which $18.5

Nurses 98

Nurses Drugs Containment Marketing 98

XTalks

OCTOBER 21, 2020

The answer may lie in the genetic code of the virus, which scientists at Duke University have found contains several silent mutations that affect protein folding. At best, it is slowly mutating, which is good news for vaccine developers as they don’t have to contend with potentially multiple strains of the virus.

RNA 98

RNA Protein Genome Genomics 98

pharmaphorum

FEBRUARY 25, 2022

The past two years have shone a spotlight on the UK life sciences industry. The UK pharma sector should emerge from COVID-19 with a great deal of goodwill in the bank, especially after rapidly developing vaccines that are helping to steer the world out of the pandemic. A reputational problem remains.

Life Science 98

Life Science Vaccine Vaccination Pharmacy 98

XTalks

DECEMBER 1, 2021

Moreover, it is also not known how the current COVID-19 vaccines and drugs will hold up against Omicron. Researchers say it will take a few weeks before more is known about the transmissibility, virulence (i.e., the severity of disease) and potential for immune evasion of Omicron. 1.1.529 variant to South Africa and the world.”.

Gene 105

Gene Genome Genomics Genetics 105

Pharma in Brief

JANUARY 24, 2021

The Canadian pharma and life sciences space saw many developments in 2020, despite and in some cases because of the COVID-19 pandemic. The industry was among the heroes of 2020, developing, commercializing and distributing drugs, vaccines, and personal protective equipment to deal with COVID-19 at remarkable speeds.

Life Science 52

Life Science Regulation Medicine Drugs 52

XTalks

MAY 24, 2022

Now, Gilead has replaced the material of the container vial with aluminosilicate glass, proving it to be a good material for storage and compatibility. “We Ongoing Clinical Trials for mRNA HIV Vaccines. The National Institutes of Health (NIH) has launched a Phase I clinical trial in March to evaluate three mRNA HIV vaccines.

Drugs 98

Drugs Clinical Trials Clinical Trials Trials 98

Pharmaceutical Technology

APRIL 24, 2023

Demand for biologics, including vaccines, is at an all-time high, in the post-Covid era. There are fewer sites for cell and gene therapies and vaccines – 90 companies with 127 facilities, as per GlobalData figures. The approval of the mRNA Covid-19 vaccine, which is a biologic, has thrust the modality even further into the spotlight.

Contract Manufacturing 130

Contract Manufacturing Manufacturing Protein Sales 130

XTalks

NOVEMBER 5, 2024

per unit, included 958,903 units, each containing one ordinary share and three warrants to purchase additional shares at an exercise price of $4.38 is advancing novel nasal spray-based hydrogels with two innovative platforms: Capture and Contain (C&C) and Trap and Target (T&T). Polyrizon Ltd., million in gross proceeds.

Drug Delivery 111

Drug Delivery Drugs Immune Response Allergies 111

The Pharma Data

OCTOBER 26, 2020

Novasep provides cost-effective and sustainable manufacturing solutions for the life sciences industries. This press release contains certain forward-looking statements concerning Sensorion and its business. The agreement covers the gene therapy program targeting OTOF (OTOF-GT), the gene encoding the otoferlin protein.

Gene Therapy 52

Gene Therapy Gene Manufacturing Production 52

The Pharma Data

DECEMBER 8, 2020

They contain proteins, nucleic acids and metabolites, which carry information from secreting to receiving cells. ABOUT SARTORIUS The Sartorius Group is a leading international partner of life science research and the biopharmaceutical industry. . EVOTEC AND SARTORIUS FORM CONSORTIUM TO SUPPORT CUREXSYS’ € 8.2

Manufacturing 52

Manufacturing Containment Life Science Production 52

XTalks

JANUARY 14, 2021

Related: COVID-19 Vaccine and Drug Development Coverage. At this time, we believe the data suggests that the currently authorized COVID-19 vaccines may still be effective against this strain. This variant contains the same N501Y mutation as B.1.1.7 So far, this does not appear to be the case for the N501Y mutation in the B.1.1.7.

Genetics 98

Genetics Genome Genomics Protein 98

Pharma in Brief

JANUARY 9, 2022

In response to the COVID-19 pandemic, in 2020, the Minister of Health signed interim orders designed to streamline the process to authorize the importation or sale of drugs, vaccines, and medical devices used to diagnose, treat, mitigate, or prevent COVID-19.

Regulation 52

Regulation Manufacturing Drugs Medicine 52